Atlas Trials

Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care

Clinical trial NCT04212390 · COMPLETED

Trial details

NCT number
NCT04212390
Sponsor
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Status
COMPLETED
Study type
OBSERVATIONAL
MDS (Myelodysplastic Syndrome)
Start date
2020-06-03
Primary completion
2024-07-18
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.